https://treventis.com/latest-news/ 2023-04-27T20:22:33+00:00 https://treventis.com/latest-news/treventis-becomes-a-resident-of-jlabs-toronto/ 2017-05-11T06:20:46+00:00 https://treventis.com/latest-news/treventis-diagnostics-highlighted-in-recent-press-articles/ 2018-01-15T06:20:12+00:00 https://treventis.com/latest-news/treventis-scientists-attend-alzheimer-association-international-conference/ 2018-07-22T12:17:04+00:00 https://treventis.com/latest-news/treventis-founder-sultan-darvesh-elected-to-canadian-academy-of-health-sciences/ 2018-09-13T12:45:28+00:00 https://treventis.com/latest-news/treventis-founder-sultan-darvesh-presents-invited-canp-lecture/ 2018-10-04T12:46:31+00:00 https://treventis.com/latest-news/treventis-attends-the-7th-world-cns-summit/ 2019-02-22T16:37:15+00:00 https://treventis.com/latest-news/treventis-adds-to-scientific-advisory-board/ 2019-03-21T14:18:05+00:00 https://treventis.com/latest-news/treventis-attends-ad-pd-2019/ 2019-04-01T16:28:54+00:00 https://treventis.com/latest-news/treventis-attends-the-bio-international-convention-gives-buzz-of-bio-presentation/ 2019-06-03T06:28:26+00:00 https://treventis.com/latest-news/treventis-founders-present-research-at-aaic-2019/ 2019-07-14T06:32:44+00:00 https://treventis.com/latest-news/treventis-attends-4th-zebrafish-for-personalized-precision-medicine-conference/ 2019-09-18T06:30:04+00:00 https://treventis.com/latest-news/treventis-ceo-invited-speaker-panelist-at-xv-international-pharma-licensing-symposium/ 2019-09-18T06:31:24+00:00 https://treventis.com/latest-news/treventis-scientists-visit-society-for-neuroscience-conference/ 2019-10-24T16:42:34+00:00 https://treventis.com/latest-news/treventis-attends-the-2nd-neuromuscular-drug-development-summit-nmd/ 2019-10-27T16:35:00+00:00 https://treventis.com/latest-news/treventis-gives-invites-presentation-at-texas-life-science-forum/ 2019-11-06T16:32:45+00:00 https://treventis.com/latest-news/treventis-attends-bioport-atlantic-conference/ 2019-11-06T16:46:48+00:00 https://treventis.com/wp-content/uploads/2019/11/BioPort_Logo_for_Web-02.png https://treventis.com/latest-news/treventis-founders-publish-new-computational-methodology-for-brain-drug-design/ 2019-12-13T18:06:05+00:00 https://treventis.com/wp-content/uploads/2019/12/jm9b01220_0012.gif https://treventis.com/latest-news/treventis-attends-tau2020-conference/ 2020-02-12T10:01:48+00:00 https://treventis.com/latest-news/treventis-attends-8th-neurodegenerative-drug-development-summit/ 2020-02-25T10:04:16+00:00 https://treventis.com/latest-news/treventis-attends-virtual-bio-conference/ 2020-06-13T14:29:26+00:00 https://treventis.com/latest-news/treventis-founders-awarded-funding-for-covid-19-clinical-trial/ 2020-07-08T14:59:38+00:00 https://treventis.com/wp-content/uploads/2020/07/fig-9-1x.jpeg https://treventis.com/latest-news/treventis-attends-virtual-aaic-2020/ 2020-08-01T14:43:20+00:00 https://treventis.com/wp-content/uploads/2020/08/15913637722020_AAIC_Virtual-e1597342086288.jpeg https://treventis.com/latest-news/treventis-scientists-and-advisors-attend-and-present-at-als-mnd-2020/ 2020-12-09T09:18:36+00:00 https://treventis.com/latest-news/treventis-vp-research-marcia-taylor-attends-ad-pd-2021/ 2021-03-15T09:17:18+00:00 https://treventis.com/latest-news/treventis-presents-at-the-targeting-protein-misfolding-summit/ 2021-03-17T09:15:06+00:00 https://treventis.com/latest-news/treventis-attends-bio-digital-conference/ 2021-06-16T06:01:04+00:00 https://treventis.com/latest-news/treventis-attends-virtual-aaic-2021/ 2021-07-31T06:02:46+00:00 https://treventis.com/wp-content/uploads/2021/07/AAIC-logo.png https://treventis.com/latest-news/treventis-attends-resi-partnering-week-2021/ 2021-09-15T06:04:26+00:00 https://treventis.com/wp-content/uploads/2021/09/RESI-logo.png https://treventis.com/latest-news/treventis-cso-mark-reed-gives-invited-lecture-at-undruggable-leaders-forum/ 2021-09-17T06:06:26+00:00 https://treventis.com/wp-content/uploads/2021/09/Undruggable-logo.png https://treventis.com/latest-news/treventis-attends-resi-nov-2021/ 2021-11-15T09:55:33+00:00 https://treventis.com/wp-content/uploads/2021/11/resi.jpeg https://treventis.com/latest-news/treventis-attending-bio-2022/ 2022-06-06T10:05:46+00:00 https://treventis.com/latest-news/dr-donald-weaver-oskar-fischer-prize-winner/ 2022-06-08T10:05:08+00:00 https://treventis.com/latest-news/treventis-founders-give-invited-lectures-at-watoc/ 2022-06-30T07:43:13+00:00 https://treventis.com/wp-content/uploads/2022/06/WATOC-2020.jpeg https://treventis.com/latest-news/treventis-founder-sultan-darvesh-awarded-jubilee-medal/ 2022-08-05T10:45:39+00:00 https://treventis.com/latest-news/treventis-awarded-2-97m-grant-from-the-u-s-department-of-defense/ 2022-10-18T10:00:30+00:00 https://treventis.com/latest-news/treventis-partners-its-preclinical-program-in-alzheimers-disease-with-takeda/ 2023-04-11T10:00:59+00:00 https://treventis.com/latest-news/takeda-joins-forces-with-small-private-biotech-for-preclinical-alzheimers-research/ 2023-04-13T17:39:26+00:00 https://treventis.com/wp-content/uploads/2023/04/EndpointsNews_logo.jpeg https://treventis.com/latest-news/takeda-licenses-small-molecule-developed-by-researchers-at-uhns-krembil-brain-institute-targeting-tau-protein-implicated-in-alzheimers-disease/ 2023-04-13T17:59:43+00:00 https://treventis.com/latest-news/takeda-partners-with-treventis-on-alzheimers-disease-research/ 2023-04-13T18:07:53+00:00 https://treventis.com/wp-content/uploads/2023/04/Treventis-news-pharma-letter.png https://treventis.com/latest-news/tech-update-a-new-approach-to-alzheimers-and-proof-that-video-calls-are-exhausting/ 2023-04-27T20:22:33+00:00